Washington, Jan 29 Modifying shape of a protein that controls inflammation may reduce progression of inflammatory bowel disease and colon cancer, according to a new study that may pave the way for therapies against the conditions. The altered protein – IRAK-M – causes the immune system to become supercharged, clearing out the bacteria before they can do any damage.